In 2012, the European Society of Thoracic Surgeons (ESTS) created the Lung Neuroendocrine Tumors Working Group (NETs-WG) with the aim to develop scientific knowledge on clinical management of such rare neoplasms. This paper outlines the outcome and prognostic factors of two aggressive NETs: atypical carcinoids (ACs) and large-cell neuroendocrine carcinomas (LCNCs).
Clinical management of atypical carcinoid and large-cell neuroendocrine carcinoma: a multicentre study on behalf of the European Association of Thoracic Surgeons (ESTS) Neuroendocrine Tumours of the Lung Working Group†
Rena, Ottavio;CASADIO, Caterina;
2015-01-01
Abstract
In 2012, the European Society of Thoracic Surgeons (ESTS) created the Lung Neuroendocrine Tumors Working Group (NETs-WG) with the aim to develop scientific knowledge on clinical management of such rare neoplasms. This paper outlines the outcome and prognostic factors of two aggressive NETs: atypical carcinoids (ACs) and large-cell neuroendocrine carcinomas (LCNCs).File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Clinical-management-of-atypical-carcinoid-and-largecell-neuroendocrine-carcinoma-A-multicent.pdf
file ad accesso aperto
Tipologia:
Versione Editoriale (PDF)
Licenza:
DRM non definito
Dimensione
469.67 kB
Formato
Adobe PDF
|
469.67 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
